About Careers MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

US Health Experts Vote in Favor of Approving New Obesity Drug

by Sheela Philomena on February 23, 2012 at 9:52 AM
Font : A-A+

 US Health Experts Vote in Favor of Approving New Obesity Drug

An advisory panel of health experts to FDA urged approval of a new obesity drug - Qnexa. The panel voted 20-2 that the FDA should allow Qnexa on the market, saying the latest overall benefit-risk assessment supported its approval.

The drug, made by California-based biotech firm Vivus, is the first obesity drug submitted to the FDA in more than a decade.

Advertisement

Qnexa combines two existing drugs, the appetite suppressant phentermine and topiramate, an anti-convulsant that can be used in conjunction with other drugs for weight loss.

The FDA does not have to follow the advice of the advisory panel, though it usually does. A final decision is expected by April 17.

Source: AFP
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
Test  Your Knowledge on Heart
Test Your Knowlege on Genes
Obesity in Teens Make Inroads into Early Atrial Fibrillation
View all
Recommended Reading
News Archive
Date
Category
Advertisement
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Bariatric Surgery Drug Toxicity Obesity Bulimia Nervosa Body Mass Index Signature Drug Toxicity Liposuction Battle of the Bulge Diabesity Hunger Fullness and Weight Control 

Most Popular on Medindia

Hearing Loss Calculator Drug - Food Interactions The Essence of Yoga Accident and Trauma Care Sinopril (2mg) (Lacidipine) Color Blindness Calculator Daily Calorie Requirements A-Z Drug Brands in India Blood Donation - Recipients Iron Intake Calculator
This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use
×

US Health Experts Vote in Favor of Approving New Obesity Drug Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests